46 -3 (65) 2024 - Navruzova Sh.I., Akhmatova G.R. - CLINICAL AND LABORATORY INDICATORS OF CERVICAL PAPILLOMAVIRUS-ASSOCIATED DISEASES IN WOMEN OF FERTILE AGE

CLINICAL AND LABORATORY INDICATORS OF CERVICAL PAPILLOMAVIRUS-ASSOCIATED DISEASES IN WOMEN OF FERTILE AGE

Navruzova Sh.I. Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmatova G.R. Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

In the article, the author describes a study on the study of clinical blood parameters in women with cervical diseases associated with HPV. Cervical diseases in women of reproductive age are an urgent problem for many states and its medical and social significance is currently increasing. The results obtained in the study contribute to the early prevention of cervical cancer in women of reproductive age, which contributes to improving the quality of preventive oncogynecological services.

Keywords: HPV, human papillomavirus, prognosis, women, fertile age, cervical cancer

First page

253

Last page

257

For citation: Navruzova Sh.I., Akhmatova G.R. - CLINICAL AND LABORATORY INDICATORS OF CERVICAL PAPILLOMAVIRUS-ASSOCIATED DISEASES IN WOMEN OF FERTILE AGE //New Day in Medicine 3(65)2024 253-257 https://newdayworldmedicine.com/en/article/3758

List of References

1. Harima Y., Sawada S., Nagata K., Sougawa M., Ohnishi T. Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy. // Int. J. Radiat. Oncol. Biol. Phys., 2018; 52: 1345–1351. doi: 10.1016/S0360-3016(01)02796-1 14.
2. Lassen P., Eriksen J.G., Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. // J. Clin. Oncol., 2019; 27: 1992 – 1998. doi: 10.1200/JCO.2008.20.2853
3. Licitra L., Perrone F., Bossi P., Suardi S., Mariani L., Artusi R., Oggionni M., Rossini C., Cantù G., Squadrelli M. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. // J. Clin. Oncol., 2016; 24: 5630-5636. doi: 10.1200/JCO.2005.04.6136
4. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsagué X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. // N. Engl. J. Med., 2013; 348: 518–527. doi: 10.1056/ NEJMoa021641
5. Snijders P.J., Verhoef V.M., Arbyn M., Ogilvie G., Minozzi S., Banzi R., van Kemenade F.J., Heideman D.A., Meijer C.J. Highrisk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. // Int. J. Cancer, 2013; 132: 2223–2236. doi: 10.1002/ijc.27790
6. Steenbergen R.D., Snijders P.J., Heideman D.A., Meijer C.J. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions. // Nat. Rev. Cancer, 2014; 14: 395–405. doi: 10.1038/nrc3728

   file

   download